The idea of digital twins -- digital representations of humans built with computer models -- for medical research is gaining traction in private and academic sectors. With predictive simulation ...

Panelists at a TIME100 Talk in Cannes, France, spoke about how AI can enhance creativity—and how to navigate the changes it’s bringing.

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

SAN FRANCISCO, CA / ACCESS Newswire / February 12, 2026 / Unlearn, a leader in AI solutions for clinical trials, today announced it is partnering with VectorY Therapeutics, a biotechnology company ...

While it is true that experiences are an indispensable part of learning to start a venture, we must not forget that focusing an idea on innovation and not on established paradigms can be much more ...

Reflecting on the importance and art of reskilling — learning and unlearning — comes at a timely moment. The Covid-19 pandemic has permitted us to learn how important soft skills are, and, more ...

Twins have long played a role in the world of medical research, specifically in the area of clinical trials, where they can help measure the effectiveness of a therapy by applying a control to one of ...